Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778 - Concepedia

Concepedia

Publication | Closed Access

Prevention and Inhibition But Not Reversion of Chronic Allograft Vasculopathy by FK778

12

Citations

39

References

2008

Year

T. Deuse, Grant Hoyt, Tomoyoshi Koyanagi, Robert C. Robbins, Sonja Schrepfer

Transplantation

Abstract

FK778 prevents the development of CAV and inhibits a progression of established disease. It shows a similar efficacy but a safer drug profile when compared to sirolimus.

References

	Year	Citations
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients Howard J. Eisen, E. Murat Tuzcu, Richard Dorent, New England Journal of Medicine	2003	1.2K
Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report—2006 David O. Taylor, Leah B. Edwards, Mark M. Boucek, The Journal of Heart and Lung Transplantation Lung TransplantationTransplantation SurgeryAdult Cardiac SurgeryTransplantationCardiovascular Disease	2006	559
Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years Anne Keogh, Peter Ruygrok, Phillip Spratt, Circulation	2004	455
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy Donna Mancini, Sean Pinney, Daniel Burkhoff, Circulation	2003	441
Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients Howard J. Eisen, Jon Kobashigawa, Anne Keogh, The Journal of Heart and Lung Transplantation TransplantationCardiovascular DiseaseControlled TrialCardiopulmonary TransplantationMedicine	2005	259
ANTIVIMENTIN ANTIBODIES ARE AN INDEPENDENT PREDICTOR OF TRANSPLANT-ASSOCIATED CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION1 Stipo Jurčević, Mark E. Ainsworth, Ariala Pomerance, Transplantation	2001	252
Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide Xiulong Xu, James W. Williams, Eric G. Bremer, Journal of Biological Chemistry	1995	218
Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Ari Mennander, Sinikka Tiisala, Jorma Halttunen, Arteriosclerosis and Thrombosis A Journal of Vascular Biology Composite AllograftImmunologyPathologyOngoing Inflammatory ResponseInflammation	1991	212
Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory Compound Richard A. Williamson, Christopher Yea, P.A. Robson, Journal of Biological Chemistry	1995	196
REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1 Karyn F. Siemasko, Anita S. Chong, James W. Williams, Transplantation InflammationCytokineB Cell AntibodyMedicineHumoral Response	1996	185

Page 1